Systimmune Inc.

1 trials 1 recruiting Commercial sponsor

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

1 Recruiting

0 Completed trials

3 Countries active

0 Unique IMPs

N/A Results reported

Phase I (Other)

Phase I (Other): 1

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Top indications

Non-small cell lung cancer stage IIIB 1 Non-small cell lung cancer 1 Non-small cell lung cancer stage I 1 Non-small cell lung cancer stage IIIA 1 Non-small cell lung cancer stage 0 1 Non-small cell lung cancer recurrent 1 Non-small cell lung cancer stage III 1 Non-small cell lung cancer stage IV 1 Non-small cell lung cancer metastatic 1 Non-small cell lung cancer stage II 1

All trials

1 total

A Phase 1 Study Evaluating the Safety, Tolerability, and Efficacy of BL-B01D1 in Subjects with Metastatic or Unresectable Non-Small Cell Lun… Recruiting

2023-506539-14-00 Phase I (Other) 3 countries

Showing 1–1 of 1 trials

← All sponsors A–Z